MLchartDataset catalogue

Bifidobacterium animalis ssp. lactis probiotic supplement

Term · Oncology and biomedicine · MLC-T-ONC-012006

An orally bioavailable, probiotic supplement containing the non-pathogenic microorganism Bifidobacterium animalis subspecies lactis, with potential immunomodulating and mucosal protective activities. Upon oral rinsing with a solution of the capsule contents in water and oral administration, the probiotic bacteria in Bifidobacterium animalis ssp. lactis probiotic supplement may help to maintain adequate colonization of the gastrointestinal (GI) tract, including the oral mucosa, by modulating the composition of the normal microflora. During colonization in the GI tract, the bacteria may form a protective intestinal barrier that may prevent both damage to the mucosal epithelia caused by toxins and attachment of potential pathogens, thereby protecting against bacterial translocation and infection. In addition, the probiotic bacteria may potentiate immunity. Altogether, this may increase immunity and prevent mucosal damage.

Table 1. Record
IdentifierMLC-T-ONC-012006
FieldOncology and biomedicine
SynonymsBifidobacterium supplement; Bifidobacterium animalis ssp. lactis supplement; Bifidobacterium animalis probiotic supplement
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-012006",
  "term": "Bifidobacterium animalis ssp. lactis probiotic supplement",
  "field": "Oncology and biomedicine",
  "definition": "An orally bioavailable, probiotic supplement containing the non-pathogenic microorganism Bifidobacterium animalis subspecies lactis, with potential immunomodulating and mucosal protective activities. Upon oral rinsing with a solution of the capsule contents in water and oral administration, the probiotic bacteria in Bifidobacterium animalis ssp. lactis probiotic supplement may help to maintain adequate colonization of the gastrointestinal (GI) tract, including the oral mucosa, by modulating the composition of the normal microflora. During colonization in the GI tract, the bacteria may form a protective intestinal barrier that may prevent both damage to the mucosal epithelia caused by toxins and attachment of potential pathogens, thereby protecting against bacterial translocation and infection. In addition, the probiotic bacteria may potentiate immunity. Altogether, this may increase immunity and prevent mucosal damage.",
  "synonyms": [
    "Bifidobacterium supplement",
    "Bifidobacterium animalis ssp. lactis supplement",
    "Bifidobacterium animalis probiotic supplement"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/bifidobacterium-animalis-ssp-lactis-probiotic-supplement/"
}

Record 3,526 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.